HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kilian Eyerich Selected Research

galactaric acid (mucic acid)

10/2022Biomarkers of disease progression in people with psoriasis: a scoping review.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kilian Eyerich Research Topics

Disease

18Psoriasis (Pustulosis Palmaris et Plantaris)
10/2022 - 01/2008
12Atopic Dermatitis (Atopic Eczema)
01/2022 - 01/2006
9Inflammation (Inflammations)
11/2022 - 01/2006
7Eczema
01/2022 - 06/2010
6Skin Diseases (Skin Disease)
01/2022 - 11/2010
6Hypersensitivity (Allergy)
09/2020 - 01/2008
4Infections
09/2021 - 01/2009
4Contact Dermatitis (Eczema, Contact)
01/2018 - 01/2008
3Autoimmune Diseases (Autoimmune Disease)
01/2020 - 09/2010
2Disease Progression
11/2022 - 10/2022
2Pain (Aches)
01/2022 - 01/2022
2Chronic Urticaria
01/2022 - 01/2021
2Pruritus (Itching)
09/2021 - 01/2021
2Urticaria (Hives)
01/2021 - 01/2020
2Allergic Contact Dermatitis
01/2021 - 01/2010
2Lichen Planus (Lichen Ruber Planus)
07/2020 - 11/2010
2Asthma (Bronchial Asthma)
01/2020 - 02/2013
2Neoplasms (Cancer)
01/2020 - 11/2012
2Acrodermatitis (Gianotti Crosti Syndrome)
07/2018 - 07/2018
2Dermatitis
01/2018 - 01/2014
2Wounds and Injuries (Trauma)
11/2015 - 02/2013
2Chronic Mucocutaneous Candidiasis
08/2011 - 11/2008
2Candidiasis (Moniliasis)
11/2008 - 12/2007
1Type 2 Diabetes Mellitus (MODY)
10/2022
1Necrosis
10/2022
1Psoriatic Arthritis
10/2022
1Human Influenza (Influenza)
01/2022
1Herpes Simplex
01/2022
1Nasopharyngitis
01/2022
1Headache (Headaches)
01/2022
1Calcinosis Cutis
11/2021
1Kaposi Varicelliform Eruption (Eczema Herpeticum)
09/2021
1Injection Site Reaction
09/2021
1Herpes Zoster
09/2021
1Conjunctivitis
09/2021
1Ulcerative Colitis
01/2021
1Edema (Dropsy)
09/2020
1Angioedema
01/2020
1Paralysis (Palsy)
01/2020
1COVID-19
01/2020

Drug/Important Bio-Agent (IBA)

12Interleukin-17 (Interleukin 17)IBA
10/2022 - 11/2008
8CytokinesIBA
01/2020 - 12/2007
7Biomarkers (Surrogate Marker)IBA
11/2022 - 01/2017
6Biological ProductsIBA
01/2022 - 10/2016
5Interleukin-22 (IL-22)IBA
11/2015 - 11/2008
4dupilumabIBA
09/2021 - 11/2019
4AntigensIBA
01/2021 - 01/2008
4HaptensIBA
01/2018 - 01/2010
4Proteins (Proteins, Gene)FDA Link
01/2018 - 12/2009
3InterleukinsIBA
10/2022 - 11/2012
3Immunoglobulin E (IgE)IBA
01/2021 - 01/2008
3ixekizumabIBA
07/2019 - 07/2018
3NickelIBA
01/2014 - 01/2008
2Ustekinumab (CNTO 1275)FDA Link
10/2022 - 01/2018
2HLA-C Antigens (HLA-C)IBA
10/2022 - 10/2022
2Omalizumab (Xolair)FDA Link
01/2022 - 01/2021
2guselkumabIBA
01/2021 - 12/2019
2secukinumabIBA
07/2019 - 04/2016
2AllergensIBA
01/2019 - 01/2009
2Toll-Like Receptor 7IBA
01/2018 - 10/2017
2Interleukin-10 (Interleukin 10)IBA
07/2014 - 12/2007
1galactaric acid (mucic acid)IBA
10/2022
1Carrier Proteins (Binding Protein)IBA
10/2022
1Immunoglobulin G (IgG)IBA
10/2022
1Kallikreins (Kallikrein)IBA
10/2022
1LipopolysaccharidesIBA
10/2022
1TyramineIBA
10/2022
1HLA-B Antigens (HLA-B)IBA
10/2022
1IntegrinsIBA
10/2022
1Macrophage Colony-Stimulating FactorIBA
10/2022
1Interleukin-13IBA
10/2022
1Adrenal Cortex Hormones (Corticosteroids)IBA
01/2022
1Cyclosporine (Ciclosporin)FDA LinkGeneric
01/2022
1baricitinibIBA
01/2022
1Janus KinasesIBA
01/2022
1AutoantibodiesIBA
01/2022
1apremilastIBA
01/2022
1Diphosphonates (Bisphosphonates)IBA
11/2021
1Pamidronate (Aredia)FDA LinkGeneric
11/2021
1upadacitinibIBA
09/2021
1Blood Proteins (Serum Proteins)IBA
01/2021
1nickel sulfateFDA Link
01/2021
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2021
1Interleukin-23 (Interleukin 23)IBA
01/2021
1Irritants (Vesicants)IBA
09/2020
1tofacitinibIBA
07/2020
1Amine Oxidase (Copper-Containing)IBA
01/2020
1AutoantigensIBA
01/2020
1AntibodiesIBA
01/2020
1Pyruvaldehyde (Methylglyoxal)IBA
01/2020
1CalcineurinIBA
01/2020
1Cholinergic Agents (Cholinergics)IBA
01/2020
1Neutralizing AntibodiesIBA
01/2020

Therapy/Procedure

9Therapeutics
11/2022 - 01/2008
3Precision Medicine
11/2022 - 02/2015
2Immunotherapy
11/2020 - 10/2018
1Emergency Treatment
01/2022
1Activities of Daily Living (ADL)
01/2022
1Contraindications
01/2022
1Blood Component Removal (Apheresis)
01/2021